[1. Faridi R, Zahra A, Khan K, Idrees M. Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer. Virol J. 2011 Jun;8:269. DOI: 10.1186/1743-422X-8-269.10.1186/1743-422X-8-269311836221635792]Search in Google Scholar
[2. Stanley MA. Pathology and epidemiology of HPV infection in females. Gynecol Oncol. 2010 May;117(2 Suppl):S5-10. DOI: 10.1016/j.ygyno.2010.01.02410.1016/j.ygyno.2010.01.02420304221]Search in Google Scholar
[3. Parkin D. The global health burden of infection associated cancers in the year 2002. Int J Cancer. 2006 Jun;118(12):3030-44. DOI: 10.1002/ijc.21731.10.1002/ijc.2173116404738]Search in Google Scholar
[4. Ibeanu OA. Molecular pathogenesis of cervical cancer. Cancer Biology & Therapy Cancer Biol Ther. 2011 Feb;11(3):295-306. DOI: 10.4161/cbt.11.3.14686.10.4161/cbt.11.3.1468621239888]Search in Google Scholar
[5. Fernandes JV, Araújo JMG, Fernandes TAAM. Biology and natural history of human papillomavirus infection. Open Access Journal of Clinical Trials.2013;5:1–12. DOI: 10.2147/OAJCT.S37741.10.2147/OAJCT.S37741]Search in Google Scholar
[6. Yugawa T, Kiyono T. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins. Rev Med Virol. 2009 Mar;19(2):97-113. DOI: 10.1002/rmv.605.10.1002/rmv.60519156753]Search in Google Scholar
[7. Habbous S, Pang V, Eng L, Xu W, Kurtz G, Liu FF, et al. p53 Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical cancer: a systematic review and meta-analysis. Clin Cancer Res. 2012 Dec;18(23):6407-15. DOI: 10.1158/1078-0432.CCR-12-1983.10.1158/1078-0432.CCR-12-198323065429]Search in Google Scholar
[8. Nunobiki O, Ueda M, Toji E, Yamamoto M, Akashi K, Sato N, et al. Genetic Polymorphism of Cancer Susceptibility Genes and HPV Infection in Cervical Carcinogenesis. Patholog Res Int. 2011;2011:364069. DOI: 10.4061/2011/364069.10.4061/2011/364069310837821660264]Search in Google Scholar
[9. Tsigris C, Chatzitheofylaktou A, Xiromeritis C, Nikiteas N, Yannopoulos A. Genetic association studies in digestive system malignancies. Anticancer Res. 2007 Sep-Oct;27(5B):3577-87.]Search in Google Scholar
[10. Moore EE, Wark JD, Hopper JL, Erbas B, Garland SM. The roles of genetic and environmental factors on risk of cervical cancer: a review of classical twin studies. Twin Res Hum Genet. 2012 Feb;15(1):79-86. DOI: 10.1375/twin.15.1.79.10.1375/twin.15.1.7922784457]Search in Google Scholar
[11. Ueda M, Hung YC, Terai Y, Kanda K, Takehara M, Yamashita H, et al. Glutathione S-transferase GSTM1, GSTT1 and p53 codon 72 polymorphisms in human tumor cells. Hum Cell. 2003 Dec;16(4):241-51. DOI: 10.1111/j.1749-0774.2003.tb00158.x.10.1111/j.1749-0774.2003.tb00158.x15147044]Search in Google Scholar
[12. Wang D, Wang B, Zhai JX, Liu DW, Sun GG. Glutathione S-transferase M1 and T1 polymorphisms and cervical cancer risk: a meta-analysis. Neoplasma. 2011;58(4):352-9. DOI: 10.4149/neo_2011_04_352.10.4149/neo_2011_04_352]Search in Google Scholar
[13. Zhen S, Hu C-M, Bian L-H. Glutathione S-Transferase Polymorphism Interactions with Smoking Status and HPV Infection in Cervical Cancer Risk: An Evidence-Based Meta-Analysis. PLoS One. 2013 Dec 31;8(12):e83497. DOI: 10.1371/journal.pone.0083497.10.1371/journal.pone.0083497]Search in Google Scholar
[14. de Carvalho CR, Silva ID, Pereira JS, de Souza CN, Focchi GR, Ribalta JC. Polymorphisms of p53, GSTM1 and GSTT1, and HPV in uterine cervix adenocarcinoma. Eur J Gynaecol Oncol. 2008;29(6):590-3.]Search in Google Scholar
[15. Ueda M, Hung YC, Terai Y, Kanda K, Takehara M, Yamashita H et al. Glutathione S-transferase GSTM1, GSTT1 and p53 codon 72 polymorphisms in human tumor cells. Hum Cell. 2003 Dec;16(4):241-51. DOI: 10.1111/j.1749-0774.2003.tb00158.x.10.1111/j.1749-0774.2003.tb00158.x]Search in Google Scholar
[16. Economopoulos KP, Choussein S, Vlahos NF, Sergentanis TN. GSTM1 polymorphism, GSTT1 polymorphism, and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer. 2010 Dec;20(9):1576-80.10.1111/IGC.0b013e3181dedeb5]Search in Google Scholar
[17. Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002 Apr 24;287(16):2114-9. DOI: 10.1001/jama.287.16.2114.10.1001/jama.287.16.2114]Search in Google Scholar
[18. Bornstein J, Bentley J, Bösze P, Girardi F, Haefner H, Menton M, et al. 2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol. 2012 Jul;120(1):166-72. DOI: 10.1097/AOG.0b013e318254f90c.10.1097/AOG.0b013e318254f90c]Search in Google Scholar
[19. Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD, et al; Members of LAST Project Work Groups. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 2012 Jul;16(3):205-42. DOI: 10.1097/LGT.0b013e31825c31dd.10.1097/LGT.0b013e31825c31dd]Search in Google Scholar
[20. Bid HK, Konwar R, Saxena M, Chaudhari P, Agrawal CG, Banerjee M. Association of glutathione S-transferase (GSTM1, T1 and P1) gene polymorphisms with type 2 diabetes mellitus in north Indian population. J Postgrad Med. 2010 Jul-Sep;56(3):176-81. DOI: 10.4103/0022-3859.68633.10.4103/0022-3859.68633]Search in Google Scholar
[21. Peralta-Zaragoza O, Bermúdez-Morales VH, Pérez-Plasencia C, Salazar-León J, Gómez-Cerón C, Madrid-Marina V. Targeted treatments for cervical cancer: a review. Onco Targets Ther. 2012;5:315-28. DOI: 10.2147/OTT.S25123.10.2147/OTT.S25123]Search in Google Scholar
[22. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papilloma-virus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999 Sep;189(1):12-9. DOI: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F]Search in Google Scholar
[23. Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer. 2007 Jan;7(1):11-22. DOI: 10.1038/nrc2050.10.1038/nrc2050]Search in Google Scholar
[24. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Tous S, et al: Retrospective International Survey and HPV Time Trends Study Group: Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010 Nov;11(11):1048-56. DOI: 10.1016/S1470-2045(10)70230-8.10.1016/S1470-2045(10)70230-8]Search in Google Scholar
[25. Chattopadhyay K. A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer. Indian J Hum Genet. 2011 Sep;17(3):132-44. DOI: 10.4103/0971-6866.92087.10.4103/0971-6866.92087]Search in Google Scholar
[26. Zoodsma M, Sijmons RH, de Vries EG, Zee AG. Familial cervical cancer: case reports, review and clinical implications. Hered Cancer Clin Pract. 2004 May 15;2(2):99-105. DOI: 10.1186/1897-4287-2-2-99.10.1186/1897-4287-2-2-99]Search in Google Scholar
[27. Liu Y, Xu LZ. Meta-analysis of association between GSTM1 gene polymorphism and cervical cancer. Asian Pac J Trop Med. 2012 Jun;5(6):480-4. DOI: 10.1016/S1995-7645(12)60083-2.10.1016/S1995-7645(12)60083-2]Search in Google Scholar
[28. Kiran B, Karkucak M, Ozan H, Yakut T, Ozerkan K, Sag S, et al. GST (GSTM1, GSTT1, and GSTP1) polymorphisms in the genetic susceptibility of Turkish patients to cervical cancer. J Gynecol Oncol. 2010 Sep;21(3):169-73. DOI: 10.3802/jgo.2010.21.3.169.10.3802/jgo.2010.21.3.169294822420922139]Search in Google Scholar
[29. Ster AM, Petrisor FM, Stan C, Pop VI. Gluthathion S-transferase M1 and T1 polymorpisms in a group of Romanian glaucoma patients. Rev Romana Med Lab. 2015;23(4):506-10. DOI: 10.1515/rrlm-2015-0048.10.1515/rrlm-2015-0048]Search in Google Scholar
[30. Catana A, Popp R, Pop M, Porojan M, Pop V, Trifa A, Petrisor F, Farcas M. Genetic polymorphism of alpha 1 antytrypsin and glutathione S transferase and lung cancer risk. European Respiratory Journal 2011 38: p1966.]Search in Google Scholar
[31. Cseh J, Pazsit E, Orsos Z, Marek E, Huszar A, Balogh S, et al. Effect of Glutathione-S-Transferase M1 and T1 Allelic Polymorphisms on HPV-induced Cervical Precancer Formation. Anticancer Res. 2011 Sep;31(9):3051-5.]Search in Google Scholar
[32. Goodman MT, McDuffie K, Hernandez B, Bertram CC, Wilkens LR, Guo C, et al. CYP1A1, GSTM1, and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population. Gynecol Oncol. 2001 May;81(2):263-9. DOI: 10.1006/gyno.2001.6154.10.1006/gyno.2001.615411330960]Search in Google Scholar
[33. Gao LB, Pan XM, Li LJ, Liang WB, Bai P, Rao L, et al. Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis. PLoS One. 2011;6(5):e20157. DOI: 10.1371/journal.pone.0020157.10.1371/journal.pone.0020157310032521629772]Search in Google Scholar
[34. McIntyre-Seltman K, Castle PE, Guido R, Schiffman M, Wheeler CM. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1165-70. DOI: 10.1158/1055-9965.EPI-04-0918.10.1158/1055-9965.EPI-04-091815894667]Search in Google Scholar
[35. Sheehan D, Meade G, Foley VM, Dowd CA. Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J. 2001 Nov;360(Pt 1):1-16. DOI: 10.1042/bj3600001.10.1042/bj3600001]Search in Google Scholar
[36. Fonseca-Moutinho JA. Smoking and Cervical Cancer. ISRN Obstet Gynecol. 2011;2011:847684. DOI: 10.5402/2011/847684.10.5402/2011/847684314005021785734]Search in Google Scholar
[37. Collins S, Rollason TP, Young LS, Woodman CBJ. Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: a longitudinal study. Eur J Cancer. 2010 Jan;46(2):405-11. DOI: 10.1016/j.ejca.2009.09.015.10.1016/j.ejca.2009.09.015280840319819687]Search in Google Scholar
[38. Byrne MM, Davila EP, Zhao W, Parker D, Hooper MW, Caban-Martinez A, et al. Cancer screening behaviors among smokers and non-smokers. Cancer Epidemiol. 2010 Oct;34(5):611-7. DOI: 10.1016/j.canep.2010.06.017.10.1016/j.canep.2010.06.01720655820]Search in Google Scholar
[39. Louie KS, Castellsague X, de Sanjose S, Herrero R, Meijer CJ, Shah K, et al. Smoking and passive smoking in cervical cancer risk: pooled analysis of couples from the IARC multicentric case-control studies. Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1379-90. DOI: 10.1158/1055-9965.EPI-11-0284.10.1158/1055-9965.EPI-11-028421610224]Search in Google Scholar
[40. Abbas M, Srivastava K, Imran M, Banerjee M. Association of Glutathione S-transferase (GSTM1, GSTT1 and GSTP1) polymorphisms and passive smoking in cervical cancer cases from North India. Int J Biomed Res. 2013;4:655-62. DOI: 10.7439/ijbr.v4i12.396.10.7439/ijbr.v4i12.396]Search in Google Scholar
[41. Sui Y, Han W, Yang Z, Jiang M. Association of glutathione S-transferase M1 and T1 null polymorphisms with the development of cervical lesions: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2011 Dec;159(2):443-8. DOI: 10.1016/j.ejogrb.2011.09.012.10.1016/j.ejogrb.2011.09.01221962942]Search in Google Scholar
[42. Rodríguez M, Mejia F, Lecourtois M, Domínguez V, Castillo J. Influence of GSTT1, GSTM1 and GSTP1 Polymorphisms on the Development of Breast Cancer. J Cancer Ther. 2014;5:552-9. DOI: 10.4236/jct.2014.56063.10.4236/jct.2014.56063]Search in Google Scholar
[43. Oliveira AL, Rodrigues FF, Santos RE, Aoki T, Rocha MN, Longui CA, et al. GSTT1, GSTM1, and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer. Genet Mol Res. 2010 Jun 11;9(2):1045-53. DOI: 10.4238/vol9-2gmr726.10.4238/vol9-2gmr72620568049]Search in Google Scholar